Skip to Main Content

Paper Details

Randomised controlled cognition trials in remitted patients with mood disorders published between 2015 and 2021: A systematic review by the International Society for Bipolar Disorders Targeting Cognition Task Force.
Bipolar Disord
19
2022
Bipolar Disorders, bipolar disorder, cognitive impairment, lurasidone, major depressive disorder, modafinil, mood disorders, patients
Author NameAffiliation
Tamsyn E Van RheenenUniversity of Melbourne
Tamsyn E Van RheenenSwinburne University
Lakshmi N YathamUniversity of British Columbia
Allan H YoungInstitute of Psychiatry, King's College London
Allan H YoungInstitute of Psychiatry, King's College London
Katherine E BurdickHarvard Medical School
Katherine E BurdickBrigham and Women's Hospital
Eduard VietaClinical Institute of Neuroscience, Hospital Clinic, University of Barcelona
  • 1 - 8

Datasets

PubMedCitations and abstracts of biomedical literatureLink
PubMedCitations and abstracts of biomedical literatureLink
PubMedCitations and abstracts of biomedical literatureLink
PubMedCitations and abstracts of biomedical literatureLink
PubMedCitations and abstracts of biomedical literatureLink
PubMedCitations and abstracts of biomedical literatureLink
PubMedCitations and abstracts of biomedical literatureLink
PubMedCitations and abstracts of biomedical literatureLink
PubMedCitations and abstracts of biomedical literatureLink
PubMedCitations and abstracts of biomedical literatureLink
PubMedCitations and abstracts of biomedical literatureLink
PubMedCitations and abstracts of biomedical literatureLink
PubMedCitations and abstracts of biomedical literatureLink
PubMedCitations and abstracts of biomedical literatureLink
PubMedCitations and abstracts of biomedical literatureLink